The out-coupling of light from an organic light-emitting diode, and thus its efficiency, strongly depends on the orientation of the transition dipole moment (TDM) of the emitting molecules with respect to the substrate surface. Despite the importance of this quantity, theoretical investigations of the direction of the TDM of phosphorescent emitters based on iridium(iii) complexes remain limited. One challenge is to find an appropriate level of theory able to accurately predict the direction of the TDM. Here, we report relativistic time-dependent density functional theory (TDDFT) calculations of the TDM, emission energies and lifetimes for both the ground-state (S0) and triplet (T1) excited-state geometries of fac-tris(2-phenylpyridyl)iridium(iii) (Ir(ppy)3), using the two-component zero-order regular approximation (ZORA) or including spin-orbit coupling (SOC) perturbatively using the simpler one-component (scalar) formulation. We show that the one- and two-component approaches give similar emission energies and overall radiative lifetimes for each individual geometry. Use of the S0 geometry leads to two of the excited triplet substates being degenerate, with the degeneracy lifted for the T1 geometry, with the latter matching experiment. Two-component calculations using the T1 geometry give results for the direction of the TDM more consistent with experiment than calculations using the S0 geometry. Finally, we show that adding a dielectric medium does not affect the direction of TDM significantly, but leads to better agreement with the experimentally measured radiative lifetime.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c9cp01045a | DOI Listing |
Biomed Pharmacother
January 2025
Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 56212, Republic of Korea. Electronic address:
Granulomas, dense clusters of immune cells and bacteria, are critical barriers in tuberculosis (TB) treatment. Recent advancements in TB management have highlighted granuloma control as a potential host-directed therapy (HDT) strategy. Although isoniazid (INH) is the first-line drug for TB therapy, its efficacy is limited to non-replicating Mycobacterium tuberculosis (Mtb) under granulomatous conditions, necessitating the development of more effective derivatives.
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
December 2024
Department of Pharmaceutical and Medical Chemistry, Clinical Pharmacy, University of Muenster, Muenster, Germany. Electronic address:
The number of prescriptions for new direct oral anticoagulants (DOACs) apixaban, edoxaban, rivaroxaban and dabigatran has increased exponentially in recent years, increasingly replacing the old gold standard, vitamin-K-antagonists. Due to their wide therapeutic range, therapeutic drug monitoring (TDM) is not required, although it has been proven that this could significantly reduce side effects. In order to develop a cost-efficient and simple method for the simultaneous detection of the DOACs and phenprocoumon, a new technology for sample preparation from capillary blood in the ambulant sector named VAMS® was integrated and an LC-MS detector with on-line solid phase extraction (SPE) applying a Turboflow HTLC Cyclone 1.
View Article and Find Full Text PDFNat Rev Gastroenterol Hepatol
December 2024
International Scientific Association for Probiotics and Prebiotics, Consulting Scientific Advisor, Centennial, CO, USA.
Cell Mol Life Sci
November 2024
Department of Physiology, CIMUS, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.
The use of incretin agonists for managing metabolic dysfunction-associated steatohepatitis (MASH) is currently experiencing considerable interest. However, whether these compounds have a direct action on MASH is still under debate. This study aims to investigate whether GLP-1R/GIPR agonists act directly in hepatocytes and hepatic stellate cells (HSCs).
View Article and Find Full Text PDFLancet Reg Health Eur
December 2024
Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!